These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31670401)

  • 1. Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.
    Grabarczyk P; Kubicka-Russel D; Kopacz A; Liszewski G; Sulkowska E; Zwolińska P; Madaliński K; Marek M; Szabelewska M; Świątek E; Laskus T; Radkowski M
    J Med Virol; 2020 Mar; 92(3):339-347. PubMed ID: 31670401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.
    Dow BC; Munro H; Buchanan I; Ferguson K; Davidson F; Lycett C; Jarvis M; Cleland A; Petrik J; Lumley S; MacLean A
    Vox Sang; 2004 Jan; 86(1):15-20. PubMed ID: 14984555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples.
    Laperche S; Nübling CM; Stramer SL; Brojer E; Grabarczyk P; Yoshizawa H; Kalibatas V; El Elkyabi M; Moftah F; Girault A; van Drimmelen H; Busch MP; Lelie N
    Transfusion; 2015 Oct; 55(10):2489-98. PubMed ID: 26013970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
    Tobler LH; Stramer SL; Lee SR; Masecar BL; Peterson JE; Davis EA; Andrews WE; Brodsky JP; Kleinman SH; Phelps BH; Busch MP
    Transfusion; 2003 Oct; 43(10):1452-9. PubMed ID: 14507279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current testing strategies for hepatitis C virus infection in blood donors and the way forward.
    Marwaha N; Sachdev S
    World J Gastroenterol; 2014 Mar; 20(11):2948-54. PubMed ID: 24659885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
    Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.